Dapivirine News and Research

RSS
Dapivirine is an experimental non-nucleoside reverse transcriptase inhibitor. A gel formulation of dapivirine is now being investigated as a vaginal microbicide.
New clinical trial aims to examine safety and use of two HIV prevention tools

New clinical trial aims to examine safety and use of two HIV prevention tools

MTN launches new study to empower teen girls with choices in HIV prevention

MTN launches new study to empower teen girls with choices in HIV prevention

IPM begins first clinical trial of vaginal rings to prevent HIV in women

IPM begins first clinical trial of vaginal rings to prevent HIV in women

NIH-supported first HIV vaccine efficacy study begins in South Africa

NIH-supported first HIV vaccine efficacy study begins in South Africa

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

HOPE study seeks to understand safety of vaginal ring in protecting women against HIV

HOPE study seeks to understand safety of vaginal ring in protecting women against HIV

Dapivirine ring can help prevent HIV-1 infection in women

Dapivirine ring can help prevent HIV-1 infection in women

Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

ASPIRE completes patient enrollment in Phase III trial of vaginal ring for HIV prevention

ASPIRE completes patient enrollment in Phase III trial of vaginal ring for HIV prevention

IPM gains exclusive worldwide rights to promising HIV prevention medicine from Janssen R&D Ireland

IPM gains exclusive worldwide rights to promising HIV prevention medicine from Janssen R&D Ireland

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

New method of protecting women from transmission of HIV is safe

New method of protecting women from transmission of HIV is safe

Novel HIV prevention products for women demonstrate safety in clinical studies

Novel HIV prevention products for women demonstrate safety in clinical studies

Women using DMPA injection more likely to acquire HIV than women using NET-EN

Women using DMPA injection more likely to acquire HIV than women using NET-EN

IPM receives US$40M from USAID to advance new HIV prevention tools for women

IPM receives US$40M from USAID to advance new HIV prevention tools for women

Dapivirine Phase III trial now underway in Africa to treat HIV in women

Dapivirine Phase III trial now underway in Africa to treat HIV in women

International Partnership for Microbicides CEO discusses research in GlobalPost interview

International Partnership for Microbicides CEO discusses research in GlobalPost interview

Large-scale trial of vaginal ring that releases anti-HIV drug announced at health summit in London

Large-scale trial of vaginal ring that releases anti-HIV drug announced at health summit in London

No added HIV risk with hormonal contraceptives

No added HIV risk with hormonal contraceptives

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa